Grifols Australia PTY Ltd

Grifols Australia was established in 1990. Based in Melbourne, we cover the Australian and New Zealand markets. Our state-of-the art of Blood Typing reagents manufacturing facility is also based in our site in Melbourne.

We offer a comprehensive portfolio of Grifols products and. Safety and quality are our top priorities as we deliver on our mission to improve the health and well-being of people around the world.

Grifols Australia

Unit 5 / 80 Fairbank Road
Clayton South
Victoria  3169
AUSTRALIA

Contact information:
Tel: +61 3 95359333
Fax: +61 3 95359300
Mail:
australia_info@grifols.com
australia_medinfo@grifols.com

 

Notification of adverse reactions
To report an adverse drug reaction click here 

Contact with Grifols

All fields are required unless otherwise stated.

Corp Contact Us Form D3

0 characters left

Data protection information

Data controller: The Grifols’ group company to which you submit the request. Purpose: To manage your requests of information, suggestions and/or queries. Legal basis: Legitimate interest. Recipients: Grifols’ group companies, Other third parties. Rights: To access, rectify and erase personal data, as well as other rights detailed in the additional information section. Additional information: For additional information on personal data protection check here.

By clicking the button below, I declare being informed that my data is being used as described in the data protection information.

Certificate and ISO policy

Grifols Australia Pty Ltd is a member of the Grifols global family of companies, founded in 1909 by Josep Antoni Grifols i Lucas. Grifols is a leader in plasma collection and a leading provider of plasma-derived medicines and other innovative biopharmaceuticals. Grifols Australia offers a comprehensive range of transfusion medicine, immunoassay and pharmacy validation solutions for clinical laboratories, blood banks and hospitals. Grifols Australia maintains ISO 9001:2008 certification and is licensed by the Therapeutic Goods Administration to develop, manufacture, and distribute in-vitro diagnostic products. Grifols Australia is committed to quality, safety, and innovation to meet the demands of patient safety as well as represent the pioneering spirit of the global organization.